Cargando…
Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate.
Exposure to di-(2-ethylhexyl) phthalate (DEHP) is prevalent based on the measurement of its hydrolytic metabolite mono-(2-ethylhexyl) phthalate (MEHP) in the urine of 78% of the general U.S. population studied in the 1999-2000 National Health and Nutrition Examination Survey (NHANES). However, despi...
Autores principales: | Kato, Kayoko, Silva, Manori J, Reidy, John A, Hurtz, Donald, Malek, Nicole A, Needham, Larry L, Nakazawa, Hiroyuki, Barr, Dana B, Calafat, Antonia M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1241862/ https://www.ncbi.nlm.nih.gov/pubmed/14998748 |
Ejemplares similares
-
Mono-(2-ethyl-5-hydroxyhexyl) phthalate promotes uterine leiomyoma cell survival through tryptophan-kynurenine-AHR pathway activation
por: Iizuka, Takashi, et al.
Publicado: (2022) -
Endocrine Adverse Effects of Mono(2-ethylhexyl) Phthalate and Monobutyl Phthalate in Male Pubertal Rats
por: Karabulut, Gözde, et al.
Publicado: (2023) -
Use of Di(2-ethylhexyl) Phthalate–Containing Medical Products and Urinary Levels of Mono(2-ethylhexyl) Phthalate in Neonatal Intensive Care Unit Infants
por: Green, Ronald, et al.
Publicado: (2005) -
Fetotoxic effects of mono-2-ethylhexyl phthalate (MEHP) in mice.
por: Tomita, I, et al.
Publicado: (1986) -
The in vitro serum protein-binding characteristics of bis-(2-ethylhexyl) phthalate and its principal metabolite, mono-(2-ethylhexyl) phthalate.
por: Griffiths, W C, et al.
Publicado: (1988)